Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1994-03-11
1997-03-11
Kight, John
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
424189, 544360, 544295, 544357, 544225, 514252, A61K 5104, C07D40100, C07D40300, C07D24102
Patent
active
056098499
ABSTRACT:
Compounds such as 4-(s'-methoxy)phenyl-[2'-N-2"-pyridinyl)-p-iodobenzamido]ethylpiperazine have affinity and specificity for serotonin 5-HT.sub.1A receptors.
REFERENCES:
patent: 5075303 (1991-12-01), Cliffe et al.
patent: 5135931 (1992-08-01), Carlier et al.
patent: 5166157 (1992-11-01), Lavielle et al.
patent: 5169845 (1992-12-01), Cliffe et al.
patent: 5177078 (1993-01-01), Ward et al.
patent: 5364849 (1994-11-01), Cliffe
patent: 5369103 (1994-11-01), Cliffe
patent: 5382583 (1995-01-01), Cliffe
patent: 5420278 (1995-05-01), Cliffe
patent: 5430033 (1995-07-01), Cliffe et al.
Van Wijngaarden et al., J. Med. Chem., 30, 1987, 2099-2104.
Hillver et al., "(S)-5-Fluoro-8-Hydroxy-2-(dipropylamino)tetralin: A Putative 5-HT.sub.1A -Receptor Antagonist [letter]", J. Med. Chem. 33: 1541-1544 (1990).
Raghupathi et al., "Analogues of the 5-HT.sub.1A Serotonin Antagonist 1-(2-Methoxyphenyl)-4-[4-(2-phthalimido)butyl) Piperazine with Reduced ].alpha..sub.1 -Adrenergic Affinity", J. Med. Chem. 34:2633-2638 (1991).
Glennon et al., "Arylpiperazine Derivatives as High-Affinity 5-HT.sub.1A Serotonin Ligands", J. Med. Chem. 31: 1968-1971 (1988).
Hjorth et al., "8-Hydroxy-2-(Di-N-Propylamino)Tetralin 8-OH-DPAT, A Potent and Selective Simplified Ergot Congener with Central 5-HT-Receptor Stimulating Activity", J. Neural Transmission 55: 169-188 (1982).
Zhuang et al., "Synthesis of (R,S)[Trans-8-Hydroxy-2-(N-n-propyl-N-3'-iodo-2'-propenyl amino]tetraline (trans-8-OH-PIPAT): A New 5-HT.sub.1A Receptor Ligand", J. Med. Chem. 36: 3161-3165 (1993).
Greuel and Glaser, "the Putative 5-HT.sub.1A Receptor Antagonists NAN-190 and BMY 7378 are Partial Agonists in the Rat Dorsal Raphe Nucleus In Vitro", Eur. J. Pharmacol 211: 211-219 (1992).
Fletcher et al., "WAY100135: A Novel, Selective Antagonist at Presynaptic and Postsynaptic 5-HT.sub.1A Receptors", Eur. J. Pharmacol. 237: 283-291 (1993).
Cliffe et al., "(S)-N-Tert-Butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanami de, (S)-WAY-100135): A Selective Antagonist at Presynaptic and Postsynaptic 5-HT.sub.1A Receptors", J. Med. Chem. 36: 1509-1510 (1993).
Fletcher, A., et al, "Silent 5-HT.sub.1A Receptor Antagonists: Utility As Research Tools and Therapeutic Agents," TIPS 4: 441-448 (1993).
Cliffe et al. "The Design of Selective 5-HT.sub.1A Receptor Antagonists". 206th ACS Meeting, MEDI Abs. #30 (1990).
Chumpradit et al., "Iodinated Tomoxetine Derivatives as Selective Ligands for Serotonin and Norepinephrine Uptake Sites", J. Med. Chem. 35: 4492-4497 (1992).
Foreman et al., "Preclinical Studies on LY228729: A Potent and Selective Serotonin.sub.1A Agonist", J. Pharm and Exp. Ther 267: 58-71 (1993).
Chapman Lara E.
Kight John
The Trustees of the University of Pennsylvania
LandOfFree
Serotonin (5-HT.sub.1A) receptor ligands and imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serotonin (5-HT.sub.1A) receptor ligands and imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotonin (5-HT.sub.1A) receptor ligands and imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-441187